Universal x-ray screening of tuberculosis has limited value, carries potentially adverse effects for patients, and creates an unnecessary cost burden, according to a study presented Monday at the 2009 RSNA meeting.
Universal x-ray screening of tuberculosis has limited value, carries potentially adverse effects for patients, and creates an unnecessary cost burden, according to a study presented Monday at the 2009 RSNA meeting.
Since most cases arise from reactivation of a dormant foci of infection, the treatment of latent tuberculosis represents a major component of the national strategy for wiping out the disease from the U.S. Thus, screening with the purified protein derivative (PPD) exam, also known as the Mantoux test, remains popular across the country.
For their parts, the American Thoracic Society and the Centers for Disease Control recommend that all PPD-positive individuals undergo routine chest radiography to exclude clinically active TB or to detect evidence of disease that would further increase risk of reactivation. However, findings from several small studies performed recently in the U.S. and abroad have found little radiographic evidence of active TB in this population, said lead investigator Dr. Ronald Eisenberg, an associate professor of radiology at Harvard.
Beginning in 2003, Eisenberg and coauthor Dr. Nira Pollock reviewed screening chest x-rays from PPD-positive individuals before their employment as healthcare workers. Using standard criteria, the investigators looked for signs of active or latent prior tuberculosis in the otherwise healthy subjects who were identified over the course of five years.
Even though abnormalities came up in the chest radiographs of 159, or about 6.1%, of 2586 PPD-positive individuals, researchers found no signs of active tuberculosis.
"The results of chest radiography did not clarify whom we should prioritize for prophylactic anti-TB treatment," Eisenberg said. "Of course, radiographic findings must be interpreted in context with the individual's exposure and medical history, so making the overall assessment of realistic reactivation risk is a significant challenge."
Nearly 60% of cases showed evidence of calcified granulomas, inflamed lymph nodes, or both. The rest came up with signs of pleural thickening (15.7%), fibrous scarring (10%), and noncalcified nodules (19.5%).
Such extremely low yield led researchers to conclude that the published guidelines for the interpretation of x-ray screening findings are inconsistent and out of date.
"Given the cumulative adverse effect and cost of chest radiography in current tuberculosis screening programs, these guidelines should be urgently revisited," Eisenberg said.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.